Steven Stein
Fortune : 4 M $ au 30/06/2026
Fortune : 4 M $ au 30/06/2026
Steven H. Stein occupe le poste de Chief Medical Officer & Executive Vice President chez Incyte Corp. Le Dr Stein est également membre du conseil d'administration de Kura Oncology, Inc. Au cours de sa carrière, le Dr Stein a été vice-président de l'oncologie mondiale chez GlaxoSmithKline (New Jersey), SVP-US Clinical Development & Medical Affairs chez Novartis Oncology, Inc. et Senior VP-US Clinical Development & Medical Affair chez Novartis Pharmaceuticals Corp. Le Dr Stein a obtenu un doctorat de l'université de Witwatersrand.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
INCYTE CORPORATION 0,02% | 16/07/2026 | 30 916 ( 0,02% ) | 4 M $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| INCYTE CORPORATION | Directeur Technique/Scientifique/R&D | 02/03/2015 |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech invests in companies located in Israel. The firm targets companies operating in the fields of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirements. | Consultant / Advisor | - |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| Sociétés | Poste | Fin |
|---|---|---|
| REPARE THERAPEUTICS INC. | Directeur/Membre du Conseil | 28/01/2026 |
| THESEUS PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 14/02/2024 |
| KURA ONCOLOGY, INC. | Directeur/Membre du Conseil | 01/05/2023 |
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Corporate Officer/Principal | 01/02/2015 |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Corporate Officer/Principal | 01/02/2015 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 10 |
|---|---|
Incyte Corp.
Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Kura Oncology, Inc.
Kura Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
University of the Witwatersrand
University of the Witwatersrand Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline (New Jersey) | |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech invests in companies located in Israel. The firm targets companies operating in the fields of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirements. | Finance |
Repare Therapeutics, Inc.
Repare Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of novel cancer therapies | Health Technology |
Theseus Pharmaceuticals, Inc.
Theseus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and supplies drugs for cancer patients | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national